A review on antitumor action of amygdalin on various types of cancers

Author:

Ramachandran Vadivelan1,Rapindra Hosalli Kirankumar1,Vijayakumar Inbakumar1,Mani Lalithkumar1,Tiwari Ruchi1,Tiwari Gaurav1

Affiliation:

1. JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India.

Abstract

Cancer can be described as the abnormal cell division which is uncontrolled and involves the destruction of neighbour cells and tissues. This condition is significantly holds up a fact that 18 million fresh cases were detected during 2018 and the prevalence rate of cancer within 0 to 74 years is 20.2%. WHO stated that 9.6 million deaths worldwide occur by this disease. A complete cure for cancer has not been found yet but in recent years researches are made in the development of site-specific drugs with low cytotoxic effect with high specificity. However, amygdalin which belongs to the nitroside group has a standout feature for the presence of cyanide in it, this cyanide involves in the decomposition of carcinogenic substances and ultimately leads to the blocking of the nutrient source to the tumor cells which inhibits further growth of cancer cells leading to the cancer cell apoptosis. Amygdalin is extensively used in various diseases such as bronchitis, nausea, leprosy, asthma, etc but recently the antitumor property was evident in a large number of in-vitro studies in various types of cancer such as breast, renal, bladder, cervical, prostate by inhibiting the growth of tumor cells, apoptosis, and reducing metastasis of tumor cells. During this review, we look upon the role of amygdalin in a range of diseases and mainly focused on the treatment of various types of cancers.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3